CA2391646A1 - Solid preparation - Google Patents
Solid preparation Download PDFInfo
- Publication number
- CA2391646A1 CA2391646A1 CA002391646A CA2391646A CA2391646A1 CA 2391646 A1 CA2391646 A1 CA 2391646A1 CA 002391646 A CA002391646 A CA 002391646A CA 2391646 A CA2391646 A CA 2391646A CA 2391646 A1 CA2391646 A1 CA 2391646A1
- Authority
- CA
- Canada
- Prior art keywords
- compound
- crystal
- drug substance
- granules
- set forth
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C07D209/16—Tryptamines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Indole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP33954799 | 1999-11-30 | ||
JP11/339547 | 1999-11-30 | ||
US09/661,577 US6458824B1 (en) | 1999-11-30 | 2000-09-14 | Solid preparation |
US09/661,577 | 2000-09-14 | ||
PCT/JP2000/008283 WO2001040182A2 (en) | 1999-11-30 | 2000-11-24 | Solid pharmaceutical preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2391646A1 true CA2391646A1 (en) | 2001-06-07 |
Family
ID=26576443
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002391646A Abandoned CA2391646A1 (en) | 1999-11-30 | 2000-11-24 | Solid preparation |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP1235801A2 (no) |
JP (1) | JP2003515587A (no) |
CN (1) | CN1433403A (no) |
AU (1) | AU1550501A (no) |
CA (1) | CA2391646A1 (no) |
CZ (1) | CZ20021833A3 (no) |
HU (1) | HUP0203865A3 (no) |
IL (1) | IL149635A0 (no) |
MX (1) | MXPA02005326A (no) |
NO (1) | NO20022541L (no) |
NZ (1) | NZ519086A (no) |
PL (1) | PL356468A1 (no) |
SK (1) | SK7362002A3 (no) |
WO (1) | WO2001040182A2 (no) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20050010512A (ko) * | 2002-06-12 | 2005-01-27 | 스미또모 세이야꾸 가부시키가이샤 | 인돌, 인다졸 및 벤즈아졸류 |
JP3759949B2 (ja) * | 2002-12-17 | 2006-03-29 | 湧永製薬株式会社 | 遮光剤及び皮膜組成物 |
LT3366283T (lt) * | 2004-01-20 | 2021-12-10 | Novartis Ag | Tiesioginio presavimo formulė ir procesas |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1070477C (zh) * | 1994-11-29 | 2001-09-05 | 大日本制药株式会社 | 吲哚衍生物 |
JPH11255743A (ja) * | 1998-03-06 | 1999-09-21 | Dainippon Pharmaceut Co Ltd | 光学活性のインドール誘導体の製造方法及びその製造中間体 |
-
2000
- 2000-11-24 HU HU0203865A patent/HUP0203865A3/hu unknown
- 2000-11-24 CA CA002391646A patent/CA2391646A1/en not_active Abandoned
- 2000-11-24 WO PCT/JP2000/008283 patent/WO2001040182A2/en not_active Application Discontinuation
- 2000-11-24 IL IL14963500A patent/IL149635A0/xx unknown
- 2000-11-24 JP JP2001541868A patent/JP2003515587A/ja not_active Withdrawn
- 2000-11-24 PL PL00356468A patent/PL356468A1/xx not_active Application Discontinuation
- 2000-11-24 NZ NZ519086A patent/NZ519086A/en unknown
- 2000-11-24 CN CN00818730A patent/CN1433403A/zh active Pending
- 2000-11-24 MX MXPA02005326A patent/MXPA02005326A/es not_active Application Discontinuation
- 2000-11-24 CZ CZ20021833A patent/CZ20021833A3/cs unknown
- 2000-11-24 SK SK736-2002A patent/SK7362002A3/sk not_active Application Discontinuation
- 2000-11-24 AU AU15505/01A patent/AU1550501A/en not_active Abandoned
- 2000-11-24 EP EP00977904A patent/EP1235801A2/en not_active Withdrawn
-
2002
- 2002-05-29 NO NO20022541A patent/NO20022541L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NZ519086A (en) | 2003-11-28 |
HUP0203865A3 (en) | 2004-05-28 |
CZ20021833A3 (cs) | 2003-02-12 |
NO20022541D0 (no) | 2002-05-29 |
HUP0203865A2 (hu) | 2003-03-28 |
WO2001040182A3 (en) | 2002-06-27 |
IL149635A0 (en) | 2002-11-10 |
JP2003515587A (ja) | 2003-05-07 |
SK7362002A3 (en) | 2003-02-04 |
NO20022541L (no) | 2002-07-29 |
PL356468A1 (en) | 2004-06-28 |
MXPA02005326A (es) | 2003-02-12 |
WO2001040182A2 (en) | 2001-06-07 |
CN1433403A (zh) | 2003-07-30 |
EP1235801A2 (en) | 2002-09-04 |
AU1550501A (en) | 2001-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2319308C (en) | Pharmaceutical agents | |
US6458824B1 (en) | Solid preparation | |
ES2239558T3 (es) | Hemitartrato de zolpidem micronizado. | |
WO2010039982A1 (en) | Crth2 modulators | |
US20060148878A1 (en) | Pseudopolymorphic forms of carvedilol | |
CA2121391A1 (en) | Indoloylguanidine derivatives | |
EP1811957A1 (en) | Solid pharmaceutical composition comprising donepezil hydrochloride | |
UA44304C2 (uk) | ІНДАЗОЛКАРБОКСАМІДИ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ НА ЇХ ОСНОВІ, СПОСІБ ВПЛИВУ НА РЕЦЕПТОР 5-НТ<sub>4</sub> СЕРОТОНІНУ, СПОСІБ ЛІКУВАННЯ АБО ПРОФІЛАКТИКИ ТА СПОСІБ ОДЕРЖАННЯ ІНДАЗОЛКАРБОКСАМІДІВ | |
EP3067353A1 (en) | A process for the preparation of solifenacin salts and their inclusion into pharmaceutical dosage forms | |
CA2391646A1 (en) | Solid preparation | |
CN102946882A (zh) | 苯基丙氨酸衍生物及其作为非肽glp-1受体调节剂的用途 | |
AU2002338726A1 (en) | Pseudopolymorphic forms of carvedilol | |
NZ248776A (en) | Imidazole-substituted piperidine derivatives; pharmaceutical compositions and preparatory methods | |
AU2004263285A1 (en) | Stable modifications of tegaserod hydrogen maleate | |
PT815105E (pt) | Derivados de piparazinona substituidos por um heterociclo como antagonistas do receptor da taquiquinina | |
AU3095600A (en) | New pharmaceutical formulation | |
US20050113410A1 (en) | Pharmaceutical salts of zafirlukast | |
US20040198794A1 (en) | Ondansetron forms and processes of making the same | |
FI106021B (fi) | Menetelmä N-[4-[5-(syklopentyylioksikarbonyyli)amino-1-metyyli-indol-3-yyli-metyyli]-3-metoksibentsoyyli]-2-metyylibentseenisulfonamidin fysikaalisen muodon valmistamiseksi | |
TW200944502A (en) | Salt forms of a 6-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene derivative, process for their manufacture and pharmaceutical compositions containing same | |
ZA200208454B (en) | Zolpidem hemitartrate. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |